Incorporated in 1993, Artegraft Inc. offers surgeons a biological alternative to synthetic grafts. Artegraft's natural collagen matrix has proven long-term patency advantages over ePTFE and other synthetic graft materials. Artegraft is also positioned as an alternative to a non-viable autogenous fistula. Artegraft was the first vascular graft approved by the FDA in 1970 and has been in continuous clinical use for over 40 years. Available in lengths from 15 to 50 cm and in 6, 7 and 8 mm diameters, Artegraft is approved for use, distal to the aorta, for segmental bypass, arterial replacement, patch graft, femoropopliteal bypass when the patient's saphenous is absent or inadequate, but is predominantly used as a hemodialysis graft.
View Top Employees from Artegraft IncWebsite | http://www.artegraft.com |
Revenue | $5 million |
Employees | View employees |
Founded | 1993 |
Address | 206 N Center Dr, North Brunswick, New Jersey 08902, US |
Phone | (732) 422-8333 |
Fax | (732) 422-8647 |
Industry | Medical Devices & Equipment, Surgical Devices, Manufacturing |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular Artegraft Inc employee's phone or email?
The Artegraft Inc annual revenue was $5 million in 2023.
Artegraft Inc is based in North Brunswick, New Jersey.
The NAICS codes for Artegraft Inc are [33, 339].
The SIC codes for Artegraft Inc are [38, 384].